Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H F Lee

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2019
Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLCWan Ling Tan, Kevin L M Chua, Chia-Chi Lin, et al.
Drug Safety|June 15, 2026
Safety and Effectiveness of Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis: A Systematic Review and Meta-analysisWei Kang, Bowie P Y Lam, Rinko Tsz Lam Lau, et al.
NPJ Digital Medicine|March 2, 2025
Developing a named entity framework for thyroid cancer staging and risk level classification using large language modelsMatrix M H Fung, Eric H M Tang, Tingting Wu, et al.
Cancer|May 7, 2015
Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinomaEdwin P Hui, Brigette B Y Ma, K C Allen Chan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2021
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal CancerCaroline Even, Hung-Ming Wang, Shau-Hsuan Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2018
Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled TrialAnthony T C Chan, Edwin P Hui, Roger K C Ngan, et al.
The Lancet Regional Health. Western Pacific|August 7, 2023
The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumoursAya El Helali, Tai-Chung Lam, Elaine Yee-Ling Ko, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2022
Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trialA T C Chan, V H F Lee, R-L Hong, et al.
Schizophrenia Research|August 23, 2012
The 3rd Schizophrenia International Research Society Conference, 14-18 April 2012, Florence, Italy: summaries of oral sessionsBrandon Abbs, Rashmin M Achalia, Adegoke O Adelufosi, et al.
Ecancermedicalscience|March 25, 2026
The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detectionCharles M Balch, Ning Liao, Dennis S C Lam, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2019
Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLCWan Ling Tan, Kevin L M Chua, Chia-Chi Lin, et al.
Drug Safety|June 15, 2026
Safety and Effectiveness of Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis: A Systematic Review and Meta-analysisWei Kang, Bowie P Y Lam, Rinko Tsz Lam Lau, et al.
NPJ Digital Medicine|March 2, 2025
Developing a named entity framework for thyroid cancer staging and risk level classification using large language modelsMatrix M H Fung, Eric H M Tang, Tingting Wu, et al.
Cancer|May 7, 2015
Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinomaEdwin P Hui, Brigette B Y Ma, K C Allen Chan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2021
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal CancerCaroline Even, Hung-Ming Wang, Shau-Hsuan Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2018
Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled TrialAnthony T C Chan, Edwin P Hui, Roger K C Ngan, et al.
The Lancet Regional Health. Western Pacific|August 7, 2023
The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumoursAya El Helali, Tai-Chung Lam, Elaine Yee-Ling Ko, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2022
Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trialA T C Chan, V H F Lee, R-L Hong, et al.
Schizophrenia Research|August 23, 2012
The 3rd Schizophrenia International Research Society Conference, 14-18 April 2012, Florence, Italy: summaries of oral sessionsBrandon Abbs, Rashmin M Achalia, Adegoke O Adelufosi, et al.
Ecancermedicalscience|March 25, 2026
The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detectionCharles M Balch, Ning Liao, Dennis S C Lam, et al.
Pageof 15